Manoj Sigdel1, Arun Kumar2, Prajwal Gyawali3, Rojeet Shrestha4, Eans Tara Tuladhar5, Bharat Jha6. 1. Lecturer, Department of Biochemistry, Manipal College of Medical Sciences , Pokhara, Nepal . 2. Assistant Professor, Department of Biochemistry, College of Medicine, West Bengal University of Health Science , Kalyani, Nadia . 3. Phd fellow, Charles Sturt University , New South Wales, 2640, Australia. 4. Assistant professor, Hokkaido University , Japan . 5. Assistant Professor, Department of Biochemistry, Institute of Medicine , Kathmandu, Nepal . 6. Professor and Head, Department of Biochemistry, Institute of Medicine , Kathmandu, Nepal .
Abstract
BACKGROUND AND OBJECTIVES: High sensitivity C-reactive protein (hsCRP) has been associated with metabolic syndrome (MetS) and its components. Several studies have suggested hsCRP to be used as a marker for the primary prevention of cardiovascular diseases. So, we aimed to evaluate the association between hsCRP levels and the components of MetS in diabetic and non-diabetic population. MATERIALS AND METHODS: Type II diabetic patients (T2DM) (n= 121) and healthy controls (n= 121) were enrolled for the study. Anthropometric measurements were taken along with blood pressure from the arm. Ten ml of blood was collected after overnight fasting for the measurement of lipid profile, hsCRP, C-peptide and glucose levels. Insulin resistance (HOMA2-IR) was estimated by HOMA2 calculator utilizing glucose and C-peptide values. All participants were classified into two groups on the basis of the presence or absence of MetS. Data were analysed through SPSS 14 software. RESULTS: hsCRP, C-peptide and HOMA2-IR were significantly higher in T2DM subjects when compared with controls. As the number of the components of MetS increased, there was a linear increase in hsCRP levels in whole study population (p trend <.001), diabetic subjects (p trend <.001), as well as in controls (p trend <.001). HOMA2-IR and hsCRP levels were found to be better than LDL cholesterol and waist circumference for predicting the presence of MetS. CONCLUSION: hsCRP was found to be better than LDL cholesterol and waist circumference for the prediction of MetS. Hence, hsCRP could be used as a defining marker of MetS in the near future.
BACKGROUND AND OBJECTIVES: High sensitivity C-reactive protein (hsCRP) has been associated with metabolic syndrome (MetS) and its components. Several studies have suggested hsCRP to be used as a marker for the primary prevention of cardiovascular diseases. So, we aimed to evaluate the association between hsCRP levels and the components of MetS in diabetic and non-diabetic population. MATERIALS AND METHODS:Type II diabeticpatients (T2DM) (n= 121) and healthy controls (n= 121) were enrolled for the study. Anthropometric measurements were taken along with blood pressure from the arm. Ten ml of blood was collected after overnight fasting for the measurement of lipid profile, hsCRP, C-peptide and glucose levels. Insulin resistance (HOMA2-IR) was estimated by HOMA2 calculator utilizing glucose and C-peptide values. All participants were classified into two groups on the basis of the presence or absence of MetS. Data were analysed through SPSS 14 software. RESULTS: hsCRP, C-peptide and HOMA2-IR were significantly higher in T2DM subjects when compared with controls. As the number of the components of MetS increased, there was a linear increase in hsCRP levels in whole study population (p trend <.001), diabetic subjects (p trend <.001), as well as in controls (p trend <.001). HOMA2-IR and hsCRP levels were found to be better than LDL cholesterol and waist circumference for predicting the presence of MetS. CONCLUSION: hsCRP was found to be better than LDL cholesterol and waist circumference for the prediction of MetS. Hence, hsCRP could be used as a defining marker of MetS in the near future.
Authors: H Hashimoto; K Kitagawa; H Hougaku; Y Shimizu; M Sakaguchi; Y Nagai; S Iyama; H Yamanishi; M Matsumoto; M Hori Journal: Circulation Date: 2001-07-03 Impact factor: 29.690
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen Journal: Lancet Date: 2000-07-22 Impact factor: 79.321
Authors: Satyesh K Sinha; Magda Shaheen; Vikash R Singh; Tripathi B Rajavashisth; Deyu Pan; Ling Sun; Keith C Norris; Susanne B Nicholas Journal: Metab Syndr Relat Disord Date: 2020-09-03 Impact factor: 2.363
Authors: Nadia R Bennett; Trevor S Ferguson; Franklyn I Bennett; Marshall K Tulloch-Reid; Novie O M Younger-Coleman; Maria D Jackson; Maureen E Samms-Vaughan; Rainford J Wilks Journal: Front Cardiovasc Med Date: 2014-12-16
Authors: Hai-Hua Chuang; Rong-Ho Lin; Wen-Cheng Li; Wei-Chung Yeh; Yen-An Lin; Jau-Yuan Chen Journal: Int J Environ Res Public Health Date: 2020-08-13 Impact factor: 4.614